Insmed Incorporated (INSM) Q2 2011 Earnings Results

Insmed Incorporated Misses on EPS — Stock Down 13.47%

Insmed's earnings report shows a significant miss on EPS, which contributed to a sharp decline in stock price. The lack of revenue data and guidance may raise concerns among investors about the company's financial health and future prospects. The stock's 13.47% drop reflects market disappointment with the results and uncertainty moving forward.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.40	N/A	-21.21%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Overall, management expressed concern over recent performance but maintained a commitment to their strategic goals. They did not provide specific guidance for future quarters.

Management acknowledged the challenges faced in the quarter.

They emphasized a focus on long-term strategies despite current setbacks.

Insmed Incorporated Misses on EPS — Stock Down 13.47%

Key numbers

Management commentary

Insmed Incorporated

More earnings this week

Insmed Incorporated Misses on EPS — Stock Down 13.47%

Key numbers

Management commentary